75N94020D00009/75N94023F00001 - ovaprene vaginal device clinical trial - emory university title: ovaprene phase 1- protocol finalization, regulatory approval, start-up, and commencement of…
Ended Awarded Last action
- Contract number
- 75N94023F00001
- Awardee
-
Emory University UEI S352L5PJLMP8
- Awarding agency
-
National Institute of Child Health and Human Development
National Institutes of Health, Department of Health and Human Services
- Obligated
- $105,550
Award facts
- Contract value 100% obligated
- $105,550.06 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 18 offers Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Atlanta, GA 30322, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | $4,873 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $6,025 | |
| Other Administrative Action | $0 | |
| Change Order | $0 | |
| Original award | $94,652 |
About this award
This federal contract award was made by the National Institute of Child Health and Human Development (NICHD), a civilian agency, to Emory University for the Ovaprene Vaginal Device Clinical Trial. The award is a delivery order contract with a cost-plus-fixed-fee pricing type and a ceiling value of $105,550.06. The contract is for finalizing the protocol, obtaining regulatory approval, starting up, and commencing recruitment, screening, and enrollment for the clinical trial of the Ovaprene vaginal device. The contract does not have a set-aside designation, indicating Emory University's technical capabilities and expertise in conducting this type of advanced research project. As a leading private research university, Emory University has a strong track record of securing federal contracts and grants across various biomedical research domains, including infectious diseases, neuroscience, cancer research, and clinical trials.
Description
75N94020D00009/75N94023F00001 - ovaprene vaginal device clinical trial - emory university title: ovaprene phase 1- protocol finalization, regulatory approval, start-up, and commencement of recruitment, screening, and enrollment for the ovaprene VAG
Quick answers
Who was awarded contract 75N94023F00001?
75N94023F00001 was awarded to Emory University by National Institute of Child Health and Human Development (National Institutes of Health) on September 28, 2023.
How much is contract 75N94023F00001 worth?
The government has obligated $105,550 on 75N94023F00001.
Is contract 75N94023F00001 an order under another contract?
Yes. 75N94023F00001 is a delivery order under 75N94020D00009, an indefinite delivery contract.
Was contract 75N94023F00001 competed?
The extent of competition for 75N94023F00001 was full and open competition. The government received 18 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award